Similar articles for PMID: 28961065

Year	Number of Results
2004	1
2005	1
2007	4
2008	3
2009	3
2010	1
2011	3
2012	5
2013	3
2014	7
2015	15
2016	15
2017	15
2018	14
2019	3
2020	5
2021	12
2022	5
2023	3
2024	0

1

Repairing Mitochondrial Dysfunction in Disease.

Sorrentino V, Menzies KJ, Auwerx J. Sorrentino V, et al. Annu Rev Pharmacol Toxicol. 2018 Jan 6;58:353-389. doi: 10.1146/annurev-pharmtox-010716-104908. Epub 2017 Sep 27. Annu Rev Pharmacol Toxicol. 2018. PMID: 28961065 Review.

2

Mitochondrial function in development and disease.

Rossmann MP, Dubois SM, Agarwal S, Zon LI. Rossmann MP, et al. Dis Model Mech. 2021 Jun 1;14(6):dmm048912. doi: 10.1242/dmm.048912. Epub 2021 Jun 11. Dis Model Mech. 2021. PMID: 34114603 Free PMC article. Review.

3

Mitochondrial Dysfunction and Signaling in Diabetic Kidney Disease: Oxidative Stress and Beyond.

Flemming NB, Gallo LA, Forbes JM. Flemming NB, et al. Semin Nephrol. 2018 Mar;38(2):101-110. doi: 10.1016/j.semnephrol.2018.01.001. Semin Nephrol. 2018. PMID: 29602393 Review.

4

Curcumin, mitochondrial biogenesis, and mitophagy: Exploring recent data and indicating future needs.

de Oliveira MR, Jardim FR, Setzer WN, Nabavi SM, Nabavi SF. de Oliveira MR, et al. Biotechnol Adv. 2016 Sep-Oct;34(5):813-826. doi: 10.1016/j.biotechadv.2016.04.004. Epub 2016 May 1. Biotechnol Adv. 2016. PMID: 27143655 Review.

5

Agent-Based Modeling of Mitochondria Links Sub-Cellular Dynamics to Cellular Homeostasis and Heterogeneity.

Dalmasso G, Marin Zapata PA, Brady NR, Hamacher-Brady A. Dalmasso G, et al. PLoS One. 2017 Jan 6;12(1):e0168198. doi: 10.1371/journal.pone.0168198. eCollection 2017. PLoS One. 2017. PMID: 28060865 Free PMC article.

6

Mitophagy: An Emerging Target in Ocular Pathology.

Skeie JM, Nishimura DY, Wang CL, Schmidt GA, Aldrich BT, Greiner MA. Skeie JM, et al. Invest Ophthalmol Vis Sci. 2021 Mar 1;62(3):22. doi: 10.1167/iovs.62.3.22. Invest Ophthalmol Vis Sci. 2021. PMID: 33724294 Free PMC article. Review.

7

Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.

Sas K, Robotka H, Toldi J, Vécsei L. Sas K, et al. J Neurol Sci. 2007 Jun 15;257(1-2):221-39. doi: 10.1016/j.jns.2007.01.033. Epub 2007 Apr 25. J Neurol Sci. 2007. PMID: 17462670 Review.

8

Mitophagy and age-related pathologies: Development of new therapeutics by targeting mitochondrial turnover.

Palikaras K, Daskalaki I, Markaki M, Tavernarakis N. Palikaras K, et al. Pharmacol Ther. 2017 Oct;178:157-174. doi: 10.1016/j.pharmthera.2017.04.005. Epub 2017 Apr 29. Pharmacol Ther. 2017. PMID: 28461251 Review.

9

Mitochondrial Quality Control as a Therapeutic Target.

Suliman HB, Piantadosi CA. Suliman HB, et al. Pharmacol Rev. 2016 Jan;68(1):20-48. doi: 10.1124/pr.115.011502. Pharmacol Rev. 2016. PMID: 26589414 Review.

10

Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.

Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA. Calabrese V, et al. J Neurol Sci. 2005 Jun 15;233(1-2):145-62. doi: 10.1016/j.jns.2005.03.012. J Neurol Sci. 2005. PMID: 15896810 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

108 results

Results by year